CNIH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.594360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.073000E-01
Normal-vs-Stage2
1.521620E-01
Normal-vs-Stage3
7.423600E-01
Normal-vs-Stage4
1.774830E-01
Stage1-vs-Stage2
4.997800E-01
Stage1-vs-Stage3
3.882800E-01
Stage1-vs-Stage4
2.561800E-01
Stage2-vs-Stage3
1.967780E-01
Stage2-vs-Stage4
3.950000E-01
Stage3-vs-Stage4
1.930820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.668220E-01
Normal-vs-AfricanAmerican
1.430770E-01
Normal-vs-Asian
2.896000E-01
Caucasian-vs-AfricanAmerican
7.251400E-01
Caucasian-vs-Asian
3.879200E-01
AfricanAmerican-vs-Asian
3.362200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.823610E-01
Normal-vs-Female
1.345560E-01
Male-vs-Female
9.095600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.372200E-01
Normal-vs-Age(41-60Yrs)
5.097800E-02
Normal-vs-Age(61-80Yrs)
2.583000E-01
Normal-vs-Age(81-100Yrs)
1.239620E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.315600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.416200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.242400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.577770E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.023400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.611200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.213200E-01
Normal-vs-Daily Drinker
3.553400E-01
Normal-vs-Weekly Drinker
3.829800E-01
Normal-vs-Occasional Drinker
7.757800E-02
Normal-vs-Social Drinker
3.258800E-01
Non Drinker-vs-Daily Drinker
8.939000E-01
Non Drinker-vs-Weekly Drinker
5.472600E-01
Non Drinker-vs-Occasional Drinker
2.326200E-02
Non Drinker-vs-Social Drinker
8.248400E-01
Daily Drinker-vs-Weekly Drinker
6.977400E-01
Daily Drinker-vs-Occasional Drinker
2.455500E-02
Daily Drinker-vs-Social Drinker
7.789200E-01
Weekly Drinker-vs-Occasional Drinker
1.854290E-02
Weekly Drinker-vs-Social Drinker
5.367000E-01
Occasional Drinker-vs-Social Drinker
8.400300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.115000E-01
Normal-vs-Grade 2
1.778000E-01
Normal-vs-Grade 3
1.935400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.076000E-01
Grade 1-vs-Grade 3
1.752230E-01
Grade 1-vs-Grade 4
4.115000E-01
Grade 2-vs-Grade 3
6.726400E-01
Grade 2-vs-Grade 4
1.778000E-01
Grade 3-vs-Grade 4
1.935400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.577600E-01
Normal-vs-NonDiabetic
1.723590E-01
Diabetic-vs-NonDiabetic
4.337800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.024200E-01
Normal-vs-NoPancreatitis
1.598000E-01
Pancreatitis-vs-NoPancreatitis
2.541500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.729960E-01
Normal-vs-N1
1.610760E-01
N0-vs-N1
8.423000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.073610E-01
Normal-vs-TP53-NonMutant
3.383400E-01
TP53-Mutant-vs-TP53-NonMutant
1.039750E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
